Cargando…
Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines
PURPOSE: Current direct-acting antiviral agents for treatment of hepatitis C virus genotype 4a (HCV-4a) have been reported to cause adverse effects, and therefore less toxic antivirals are needed. This study investigated the role of curcumin chitosan (CuCs) nanocomposite as a potential anti-HCV-4a a...
Autores principales: | Loutfy, Samah A, Elberry, Mostafa H, Farroh, Khaled Yehia, Mohamed, Hossam Taha, Mohamed, Aya A, Mohamed, ElChaimaa B, Faraag, Ahmed Hassan Ibrahim, Mousa, Shaker A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184126/ https://www.ncbi.nlm.nih.gov/pubmed/32368050 http://dx.doi.org/10.2147/IJN.S241702 |
Ejemplares similares
-
Antiviral Activity of Chitosan Nanoparticles and Chitosan Silver Nanocomposites against Alfalfa Mosaic Virus
por: El-Ganainy, Sherif Mohamed, et al.
Publicado: (2023) -
Formulation of Quaternized Aminated Chitosan Nanoparticles for Efficient Encapsulation and Slow Release of Curcumin
por: Omer, Ahmed M., et al.
Publicado: (2021) -
Synthesis, Characterization and Cytotoxic Evaluation of Graphene Oxide Nanosheets: In Vitro Liver Cancer Model
por: Loutfy, Samah A, et al.
Publicado: (2017) -
Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Corrigendum]
Publicado: (2021) -
Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines [Retraction]
Publicado: (2022)